Fuhrlinger, K; Kniepeiss, D; Schrem, H; Mathe, Z; Schemmer, P; Muller, H; Iberer, F; Tscheliessnigg, K.
LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2019; 32: 24-25.-28th Annual Congress of the German Transplantation Society; 17. – 19.10.2019; Hannover, Deutschland.
[Oral Communication]
Web of Science